Clinical Trial Update: A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's Disease [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating vedolizumab with and without upadacitinib in adults with Crohn's disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Upadacitinib (upadacitinib)
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Crohn's Disease | Phase 3 | Status: RECRUITING